![]() |
||||||
|
Program Information
Quick Links
|
Primer on Tumor Immunology and Biological Therapy
|
||||||||||||||||||||||||||||||
| Thursday, October 30 | |
| 8:00 am - 8:05 am | Welcome and Introductions |
| 8:05 am - 8:50 am | Cytokines Mario Sznol, MD - Yale University School of Medicine |
| 8:50 am - 9:35 am | Antibody Therapy of Cancer Lee M. Nadler, MD - Dana-Farber Cancer Institute |
| 9:35 am - 10:20 am | Anti-Angiogenic Therapies David A. Cheresh, PhD – University of California, San Diego |
| 10:20 am - 10:35 am | Break |
| 10:35 am - 11:20 am | Mechanisms of Immune-Mediated Tumor Lysis William J. Murphy, PhD - University of Nevada School of Medicine |
| 11:20 am - 12:05 pm | Blocking Anti-T Cell Checkpoints James Allison, PhD - Memorial Sloan-Kettering Cancer Center |
| 12:05 pm - 1:00 pm | Lunch |
| 1:00 pm - 1:45 pm | Approach to Identification and Therapeutic Exploitation of Tumor Antigens Walter J. Urba, MD, PhD - Earle A. Chiles Research Institute |
| 1:45 pm - 2:30 pm | T Reg Cells Speaker TBC |
| 2:30 pm - 3:15 pm | Adoptive T Cell Therapy Phillip D. Greenberg, MD - Fred Hutchison Cancer Research Center & University of Washington |
| 3:15 pm - 3:30 pm | Break |
| 3:30 pm - 4:15 pm | Immune Monitoring of Cancer Immunotherapy Michael D. Kalos, PhD - City of Hope Cancer Center |
| 4:15 pm - 5:00 pm | Immune Adjuvants A. Karolina Palucka, MD, PhD - Baylor Institute for Immunology Research |